资讯

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN ...
As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...
Discover the top stock picks by market experts Raja Venkatraman, MarketSmith India, Ankush Bajaj and Trade Brains for ...
Abbott India, Aurobindo Pharma, Cipla, Dr Lal PathLabs and Torrent Pharma are the 5 pharma stocks that have flagged a caution signal on the technical charts. Technically, these 5 stocks have seen a ...
1a). This has led to the suggestion that biotechnology is not delivering on its promise to increase the rate of innovation because it has co-opted the pharmaceutical industry's ageing business ...
The White House is trying to reassure the public that pharmaceutical innovation and drug company profits won't be harmed under President Trump's new Executive Order that aims to drastically lower ...
It argues that a proper understanding of the actual informational resources at play in drugs reveals that pharmaceutical innovation can, significantly does ... I also wish to thank the editorial staff ...
Despite these pressures, the sector is transitioning toward innovation-driven growth, with government-backed initiatives streamlining drug approvals and encouraging R&D investment in high-impact ...
Critically, the Journal of Independent Medicine would take no funding or advertising revenue from the pharmaceutical industry. JIM would publish any scientific research that meets its standards ...
The biopharmaceutical industry’s return on investment in innovation is on an upward trajectory, according to a new report from Deloitte. The 15th annual ‘Measuring the Return from Pharmaceutical ...
Despite this downturn, the landscape of pharmaceutical innovation remains vibrant, particularly among smaller companies, which are making significant strides in addressing unmet medical needs ...